港股異動 | 遭剔出MSCI明晟香港指數 希慎興業(0014.HK)等相關4股普跌
格隆匯11月13日丨MSCI明晟最新公佈半年度檢討結果,環球指數系列之香港指數沒有納入股份,並剔出包括希慎興業、美高梅等在內的4只股份,所有變動均在11月26日收市後生效。今日相關股票普跌,希慎興業(0014.HK)跌逾4%,九龍倉集團跌逾3%,香格里拉(亞洲)、美高梅中國均跌逾2%。個股方面,根據港交所最新權益披露資料顯示,希慎興業於11月6日獲貝萊德以每股均價31.7316港元,增持22.9萬股,總價約726.65萬港元。美高梅今年第3季度EBITDA同比增長38.6%,國泰君安指其未能達到預期。由於公司盈利不及預期,可能會在下一份公司報告中下調盈利預測和目標價,目前對美高梅評級為“買入”,目標價13.9港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.